Supawat Thongthip
Stock Analyst at Truist Financial
(2.23)
# 3,224
Out of 4,651 analysts
13
Total ratings
53.8%
Success rate
4%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Supawat Thongthip
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| STRO Sutro Biopharma | Reiterated: Buy | $50 | $20.48 | +144.14% | 3 | Aug 13, 2026 | |
| AVBP ArriVent BioPharma | Maintained: Buy | $45 | $29.51 | +52.49% | 1 | Aug 13, 2026 | |
| IMNM Immunome | Maintained: Buy | $38 | $27.20 | +39.71% | 3 | Aug 12, 2026 | |
| JANX Janux Therapeutics | Maintained: Buy | n/a | $16.12 | - | 2 | Aug 7, 2026 | |
| RCUS Arcus Biosciences | Reiterated: Buy | n/a | $29.48 | - | 4 | Aug 6, 2026 |
Sutro Biopharma
Aug 13, 2026
Reiterated: Buy
Price Target: $50
Current: $20.48
Upside: +144.14%
ArriVent BioPharma
Aug 13, 2026
Maintained: Buy
Price Target: $45
Current: $29.51
Upside: +52.49%
Immunome
Aug 12, 2026
Maintained: Buy
Price Target: $38
Current: $27.20
Upside: +39.71%
Janux Therapeutics
Aug 7, 2026
Maintained: Buy
Price Target: n/a
Current: $16.12
Upside: -
Arcus Biosciences
Aug 6, 2026
Reiterated: Buy
Price Target: n/a
Current: $29.48
Upside: -